Works matching AU Dey, Nandini
Results: 29
A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers.
- Published in:
- Biomedicines, 2023, v. 11, n. 5, p. 1326, doi. 10.3390/biomedicines11051326
- By:
- Publication type:
- Article
Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers.
- Published in:
- Biomedicines, 2023, v. 11, n. 1, p. 112, doi. 10.3390/biomedicines11010112
- By:
- Publication type:
- Article
A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancers.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 2, p. 467, doi. 10.62347/NJRZ3602
- By:
- Publication type:
- Article
RAC1 Takes the Lead in Solid Tumors.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 5, p. 382, doi. 10.3390/cells8050382
- By:
- Publication type:
- Article
Promise of Precision Medicine in Cancers: Lessons Learned.
- Published in:
- South Dakota Medicine, 2017, v. 70, n. 11, p. 486
- By:
- Publication type:
- Article
Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3441, doi. 10.3390/ijms25063441
- By:
- Publication type:
- Article
Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 11079, doi. 10.3390/ijms241311079
- By:
- Publication type:
- Article
Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to Drugs.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6449, doi. 10.3390/ijms24076449
- By:
- Publication type:
- Article
Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 17, p. 9121, doi. 10.3390/ijms22179121
- By:
- Publication type:
- Article
Mutation-Driven Signals of ARID1A and PI3K Pathways in Ovarian Carcinomas: Alteration Is An Opportunity.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 22, p. 5732, doi. 10.3390/ijms20225732
- By:
- Publication type:
- Article
Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Wnt signaling in triple negative breast cancer is associated with metastasis.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-537
- By:
- Publication type:
- Article
Wnt signaling in triple negative breast cancer is associated with metastasis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Triple Fluorescence staining to Evaluate Mechanism-based Apoptosis following Chemotherapeutic and Targeted Anti-cancer Drugs in Live Tumor Cells.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-31575-3
- By:
- Publication type:
- Article
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 5, p. 455, doi. 10.3390/ph14050455
- By:
- Publication type:
- Article
Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab‑refractory breast cancer model.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab-refractory breast cancer model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 4, p. 733, doi. 10.1007/s00280-013-2233-7
- By:
- Publication type:
- Article
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 867, doi. 10.1007/s00280-013-2078-0
- By:
- Publication type:
- Article
Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4577, doi. 10.3390/cancers14194577
- By:
- Publication type:
- Article
Precision Medicine in Solid Tumors: How Far We Traveled So Far?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2871, doi. 10.3390/cancers14122871
- By:
- Publication type:
- Article
Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1519, doi. 10.3390/cancers14061519
- By:
- Publication type:
- Article
Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5246, doi. 10.3390/cancers13205246
- By:
- Publication type:
- Article
Clinical Utility of Next-Generation Sequencing-Based Panel Testing under the Universal Health-Care System in Japan: A Retrospective Analysis at a Single University Hospital.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1121, doi. 10.3390/cancers13051121
- By:
- Publication type:
- Article
Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 458, doi. 10.3390/cancers13030458
- By:
- Publication type:
- Article
Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1541, doi. 10.3390/cancers12061541
- By:
- Publication type:
- Article
Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077425
- By:
- Publication type:
- Article
CSK Controls Retinoic Acid Receptor (RAR) Signaling: a RAR-c-SRC Signaling Axis Is Required for Neuritogenic Differentiation.
- Published in:
- Molecular & Cellular Biology, 2007, v. 27, n. 11, p. 26, doi. 10.1128/MCB.01352-06
- By:
- Publication type:
- Article